Your Patients Can't Find Abreva — Here's How You Can Help

You've heard it from patients more than once: "I went to three pharmacies and nobody has Abreva." As an OTC product, Abreva (Docosanol 10% cream) doesn't require your prescription, but the growing availability challenges mean patients are increasingly turning to you for solutions.

This guide provides actionable steps you can take to help patients access cold sore treatment efficiently, reduce follow-up calls to your office, and integrate practical tools into your workflow.

Current Availability Landscape

Abreva remains intermittently available at major retail pharmacies in 2026. Key facts:

• Not in formal shortage: The FDA has not listed Abreva or Docosanol on its drug shortage database
• Retail stock-outs are common: High seasonal demand, limited shelf space, and a single manufacturer (Haleon) create predictable availability gaps
• Generic exists but isn't widely stocked: Docosanol 10% cream is available generically for $16 to $22, but many pharmacies don't carry it
• Price range: Brand Abreva costs $15 to $35; prescription alternatives range from $10 to $50 for generics

For the full supply picture, see our clinical briefing on the Abreva shortage for providers.

Why Your Patients Can't Find It

Understanding the root causes helps you counsel patients effectively:

Demand-Supply Mismatch

Cold sore outbreaks cluster during fall and winter when illness, stress, and immune suppression are at their peak. Pharmacies stock small quantities of Abreva (typically 3 to 6 units), so even moderate demand can empty shelves.

Single Manufacturer Bottleneck

Haleon is the sole producer of branded Abreva. Any production, packaging, or distribution delay has an outsized impact. Unlike drugs with multiple generic manufacturers, there's no alternative supply source to absorb demand surges.

OTC Product Stocking Dynamics

Unlike prescription medications where pharmacists actively manage inventory, OTC products are restocked based on automated retail inventory systems. These systems may not respond quickly to sudden demand increases, creating lag between sell-through and replenishment.

Consumer Behavior

When patients hear about availability issues, some buy extra tubes as a precaution, further depleting stock. This hoarding effect amplifies the availability problem.

What Providers Can Do: 5 Practical Steps

Step 1: Recommend Medfinder for Real-Time Stock Checking

Medfinder allows patients to check which pharmacies near them have Abreva in stock in real time. This is the single most effective recommendation you can make to reduce patient frustration and unnecessary office calls.

Consider adding Medfinder to your patient handouts or after-visit summaries for HSV-1 patients. A simple note like: "If you can't find Abreva, check medfinder.com to see which pharmacies near you have it in stock" can save significant time for both patients and your staff.

Step 2: Educate About Generic Docosanol

Many patients don't know that generic Docosanol 10% cream exists. It's the same active ingredient as Abreva, works identically, and costs $16 to $22. While not all pharmacies stock it, patients who ask specifically for "generic Docosanol" may find it available when Abreva isn't.

This is also an opportunity to educate patients about the mechanism of action so they understand why generic Docosanol is therapeutically equivalent.

Step 3: Prescribe Oral Antivirals Proactively

For patients with recurrent HSV-1 (3+ outbreaks per year), consider prescribing Valacyclovir with the instruction to take it at the first sign of an outbreak. Recommended dosing for episodic treatment:

• Valacyclovir: 2,000mg twice daily for 1 day (two doses, 12 hours apart)
• Acyclovir (oral): 400mg five times daily for 5 days

Having a prescription on hand eliminates the frantic search for OTC products during an active outbreak. Generic Valacyclovir costs as little as $15 to $25 with discount cards.

Step 4: Offer Telehealth for Acute Outbreaks

Cold sore prescriptions are ideal for telehealth. When a patient calls during an outbreak unable to find Abreva, a 5-minute telehealth visit can result in a Valacyclovir or Acyclovir prescription sent directly to their pharmacy. This keeps your in-person schedule open for more complex visits while getting the patient treated quickly.

Step 5: Create a Patient Handout

Develop a one-page resource for cold sore patients that includes:

• How to find Abreva and generic Docosanol (including Medfinder)
• When to call for a prescription alternative
• Basic cold sore management tips (avoid triggers, early treatment, sun protection)
• Links to patient education resources

This proactive approach reduces repeat calls and empowers patients to manage their condition.

Prescribing Alternatives: Quick Reference

When patients need a prescription alternative to Abreva:

• First-line oral: Valacyclovir 2,000mg PO BID x 1 day — fast, convenient, widely available ($15-$50 generic)
• First-line topical: Acyclovir 5% cream, apply 5x daily for 4 days ($15-$30 generic)
• Second-line topical: Penciclovir 1% cream, apply q2h while awake for 4 days ($30-$80+)
• Oral alternative: Acyclovir 400mg PO 5x daily for 5 days ($10-$25 generic)

For patients seeking more information, direct them to our alternatives guide and drug interactions resource.

Workflow Tips

EMR Templates

Create a smart phrase or EMR template for recurrent HSV-1 visits that includes:

• Standard counseling on early treatment initiation
• OTC recommendation: Abreva (Docosanol 10%) or generic equivalent
• Prescription backup: Valacyclovir PRN for outbreaks
• Patient resources: Medfinder for pharmacy stock checking

Staff Training

Train your nursing and front desk staff to field Abreva availability questions. Common responses they can offer:

• "You can check real-time pharmacy availability at medfinder.com"
• "Ask your pharmacist about generic Docosanol — it's the same medication"
• "If you'd like a prescription alternative, we can schedule a quick telehealth visit"

Pharmacy Collaboration

If you have preferred pharmacy partners, communicate with them about stocking generic Docosanol. Some independent pharmacies are willing to increase their OTC antiviral inventory when they know providers are recommending it.

Final Thoughts

Abreva availability challenges create unnecessary friction in cold sore treatment. As a provider, you're uniquely positioned to bridge the gap between your patients' needs and the products available to them. By recommending real-time stock tools like Medfinder, educating about generics, and prescribing alternatives proactively, you can ensure your patients always have access to effective treatment.

For the full clinical perspective on the Abreva supply situation, see our provider shortage briefing. For cost-saving guidance to share with patients, see the provider's guide to helping patients save on Abreva.